Delivery Order SPE2DB22D3011-SPE2DB24FP9ES
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 0.5% erythromycin eye ointment. The contract has a potential value of $1,006.20 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp holds an indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide $1,112.57 worth of Erythromycin Ophthalmic supplies. The delivery order has a completion date of January 31, 2024 and was awarded on December 26, 2023. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,360.25 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the provision of ERYTHROMYCIN 0.5% EYE OINTMENT to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of Erythromycin 0.5% eye ointment with a potential value of $1,281.36 and a performance period through March 6, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the delivery of 4564007458 - Erythromycin 0.5% Eye Ointment, 3.5 gram, to support Department of Defense medical treatment programs and facilities. The order has an ultimate completion date of March 20, 2024 and a ceiling value of $3,143.01. Amerisourcebergen Drug Corp holds an Indefinite...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,007,396 units of Erythromycin 0.5% Eye Ointment in 3.5 gram tubes. The contract has a ceiling value of $1,726.35 and a period of performance through March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not designated as...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Erythromycin 0.5% Eye Ointment 3.5 GM. The contract has a potential value of $3,970.97 and a completion date of February 5, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This delivery order is issued under an Indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, for the supply of erythromycin ophthalmic products. The order has a completion date of January 31, 2024 and a potential value of $1,112.57. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,084.30 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5 gram units. This firm fixed-price delivery order, awarded on January 9, 2026, with an ultimate completion date of January 12, 2026, represents a non-set-aside, competitively awarded contract. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen Drug Corp's corporate office. AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a $2,475.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment, with an ultimate completion date of September 29, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was performed at AmerisourceBergen's corporate office location in...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FP9ESDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563636950 - Erythromycin 0.5% Eye Ointment 3.5GM. The order has a potential value of $1,544.00 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is not associated with any set-aside designations. Additionally, Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense, with firm fixed price task orders issued under the IDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 2/12/24 |